{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T20:44:10Z","timestamp":1791146650348,"version":"4.1.0"},"reference-count":140,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,30]],"date-time":"2014-11-30T00:00:00Z","timestamp":1417305600000},"content-version":"vor","delay-in-days":1064,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1111\/j.1469-0691.2011.03734.x","type":"journal-article","created":{"date-parts":[[2011,11,20]],"date-time":"2011-11-20T21:41:56Z","timestamp":1321825316000},"page":"18-29","source":"Crossref","is-referenced-by-count":219,"title":["Colistin: new lessons on an old antibiotic"],"prefix":"10.1016","volume":"18","author":[{"given":"D.","family":"Yahav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Farbman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Leibovici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1469-0691.2011.03734.x_bib1","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1086\/429323","article-title":"Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections","volume":"40","author":"Falagas","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib2","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1128\/AAC.45.3.781-785.2001","article-title":"In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis","volume":"45","author":"Li","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib3","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/QCO.0b013e328332e672","article-title":"Colistin in the 21st century","volume":"22","author":"Nation","year":"2009","journal-title":"Curr Opin Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib4","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-72-6-857","article-title":"Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy","volume":"72","author":"Koch-Weser","year":"1970","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/595011","article-title":"Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America","volume":"48","author":"Boucher","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib6","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1146\/annurev.bi.46.070177.003451","article-title":"Polymyxin and related peptide antibiotics","volume":"46","author":"Storm","year":"1977","journal-title":"Annu Rev Biochem"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib7","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1128\/AAC.43.6.1317","article-title":"Peptide antibiotics","volume":"43","author":"Hancock","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib8","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1021\/jm900999h","article-title":"Structure\u2013activity relationships of polymyxin antibiotics","volume":"53","author":"Velkov","year":"2010","journal-title":"J Med Chem"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib9","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1128\/AAC.44.12.3317-3321.2000","article-title":"Interactions of bacterial cationic peptide antibiotics with outer and cytoplasmic membranes of Pseudomonas aeruginosa","volume":"44","author":"Zhang","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib10","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1128\/JB.164.3.1256-1261.1985","article-title":"Binding of polycationic antibiotics and polyamines to lipopolysaccharides of Pseudomonas aeruginosa","volume":"164","author":"Peterson","year":"1985","journal-title":"J Bacteriol"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib11","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1128\/MMBR.20.1.14-27.1956","article-title":"The properties and mode of action of the polymyxins","volume":"20","author":"Newton","year":"1956","journal-title":"Bacteriol Rev"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib12","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1586\/14787210.5.6.951","article-title":"Alternative mechanisms of action of cationic antimicrobial peptides on bacteria","volume":"5","author":"Hale","year":"2007","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib13","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1007\/s00018-009-0129-9","article-title":"Gramicidin S and polymyxins: the revival of cationic cyclic peptide antibiotics","volume":"66","author":"Mogi","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib14","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nrmicro1098","article-title":"Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?","volume":"3","author":"Brogden","year":"2005","journal-title":"Nat Rev Microbiol"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF01644448","article-title":"Comparison of the binding of gram-negative bacterial endotoxin by polymyxin B sulphate, colistin sulphate and colistin sulphomethate sodium","volume":"14","author":"Rogers","year":"1986","journal-title":"Infection"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib16","unstructured":"FDA. Coly-Mycin M Parenteral, (Colistimethate for Injection, USP). NDA 50-108\/S-026 [serial on the Internet]. Available at: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2009\/050108s026lbl.pdf (last accessed 1 December 2011)."},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib17","doi-asserted-by":"crossref","first-page":"4924","DOI":"10.1128\/AAC.00786-09","article-title":"In vitro activity of colistin (polymyxin E) against 3,480 isolates of gram-negative bacilli obtained from patients in Canadian hospitals in the CANWARD study, 2007\u20132008","volume":"53","author":"Walkty","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib18","article-title":"European Committee on Antimicrobial Susceptibility Testing","year":"2011","journal-title":"Breakpoint tables for interpretation of MICs and zone diameters. Version 13"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib19","series-title":"Twenty-First Informational Supplement [serial on the Internet]","article-title":"Performance standards for antimicrobial susceptibility testing","year":"2011"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib20","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S1473-3099(06)70580-1","article-title":"Colistin: the re-emerging antibiotic for multidrug-resistant gram-negative bacterial infections","volume":"6","author":"Li","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib21","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/jac\/dkm305","article-title":"High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea","volume":"60","author":"Ko","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib22","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1128\/AAC.00766-07","article-title":"Colistin heteroresistance in Acinetobacter and its association with previous colistin therapy","volume":"52","author":"Hawley","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib23","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1128\/AAC.00103-06","article-title":"Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii","volume":"50","author":"Li","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib24","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jinf.2008.11.002","article-title":"Colistin hetero-resistance in multidrug-resistant Acinetobacter baumannii clinical isolates from the Western Pacific region in the SENTRY antimicrobial surveillance programme","volume":"58","author":"Yau","year":"2009","journal-title":"J Infect"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib25","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1093\/jac\/dkr007","article-title":"Colistin heteroresistance in carbapenemase-producing Klebsiella pneumoniae","volume":"66","author":"Meletis","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib26","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/jac\/dkn425","article-title":"In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae","volume":"62","author":"Poudyal","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib27","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.1128\/AAC.05028-11","article-title":"Clinically relevant plasma concentrations of colistin in combination with imipenem enhance pharmacodynamic activity against multidrug-resistant Pseudomonas aeruginosa at multiple inocula","volume":"55","author":"Bergen","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib28","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1093\/jac\/dkl562","article-title":"Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster","volume":"59","author":"Antoniadou","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib29","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/CCM.0B013E3181652FAE","article-title":"Risk factors associated with the isolation of colistin-resistant gram-negative bacteria: a matched case-control study","volume":"36","author":"Matthaiou","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib30","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1089\/mdr.2010.0145","article-title":"Identification of nonclonal Pseudomonas aeruginosa isolates with reduced colistin susceptibility in Korea","volume":"17","author":"Lee","year":"2011","journal-title":"Microb Drug Resist"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib31","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1378\/chest.10-0167","article-title":"Pneumonia due to Pseudomonas aeruginosa: Part II: Antimicrobial resistance, pharmacodynamic concepts, and antibiotic therapy","volume":"139","author":"Sun","year":"2011","journal-title":"Chest"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib32","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jcf.2008.02.003","article-title":"Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients","volume":"7","author":"Johansen","year":"2008","journal-title":"J Cyst Fibros"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib33","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ijantimicag.2011.02.008","article-title":"Correlation between overexpression and amino acid substitution of the PmrAB locus and colistin resistance in Acinetobacter baumannii","volume":"37","author":"Park","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib34","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1365-2958.2000.01956.x","article-title":"Temperature-regulated efflux pump\/potassium antiporter system mediates resistance to cationic antimicrobial peptides in Yersinia","volume":"37","author":"Bengoechea","year":"2000","journal-title":"Mol Microbiol"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib35","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1128\/AAC.00834-10","article-title":"Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production","volume":"54","author":"Moffatt","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib36","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1128\/AAC.00035-06","article-title":"Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa","volume":"50","author":"Bergen","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib37","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1476-5381.1964.tb01610.x","article-title":"Sodium sulphomethyl derivatives of polymyxins","volume":"23","author":"Barnett","year":"1964","journal-title":"Br J Pharmacol Chemother"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib38","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1128\/AAC.00103-08","article-title":"Stability of colistin methanesulfonate in pharmaceutical products and solutions for administration to patients","volume":"52","author":"Wallace","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib39","series-title":"Veterinary medicines and inspections","year":"2002"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib40","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1128\/AAC.00101-06","article-title":"Use of international units when dosing colistin will help decrease confusion related to various formulations of the drug around the world","volume":"50","author":"Falagas","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib41","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1128\/AAC.00756-06","article-title":"Defining the dosage units for colistin methanesulfonate: urgent need for international harmonization","volume":"50","author":"Li","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib42","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1469-0691.2011.03667.x","article-title":"Colistin pharmacokinetics: the fog is lifting","volume":"18","author":"Couet","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib43","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.1128\/AAC.00345-09","article-title":"Penetration of colistin into cerebrospinal fluid","volume":"53","author":"Markantonis","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib44","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1227\/00006123-198006000-00016","article-title":"Antimicrobial agents and the central nervous system","volume":"6","author":"Everett","year":"1980","journal-title":"Neurosurgery"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib45","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s10096-001-0680-2","article-title":"Cerebrospinal fluid penetration and pharmacokinetic\/pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis","volume":"21","author":"Jimenez-Mejias","year":"2002","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib46","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1128\/AAC.01799-09","article-title":"Serum and cerebrospinal fluid levels of colistin in pediatric patients","volume":"54","author":"Antachopoulos","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib47","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/j.1469-0691.2009.03019.x","article-title":"Intrathecal colistin for drug-resistant Acinetobacter baumannii central nervous system infection: a case series and systematic review","volume":"16","author":"Khawcharoenporn","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib48","series-title":"Principles and practice of infectious diseases, 7th edn.","author":"Mandell","year":"2010"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib49","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1378\/chest.10-0463","article-title":"Steady-state pharmacokinetics and BAL concentration of colistin in critically ill patients after IV colistin methanesulfonate administration","volume":"138","author":"Imberti","year":"2010","journal-title":"Chest"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib50","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1378\/chest.10-1860","article-title":"Colistin penetration in the alveolar lining fluid of critically ill patients treated with IV colistimethate sodium","volume":"139","author":"Markou","year":"2011","journal-title":"Chest"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib51","unstructured":"Optimizing Dosing of Colistin for Infections Resistant to all other Antibiotics, Approved NIH Protocol Dated 12.06.07 (DMID Protocol#07-0036). NCT00235690. Available at: http:\/\/clinicaltrials.gov\/ (last accessed 1 December 2011)."},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib52","unstructured":"Population Pharmacokinetic Study of Colistin in Patients Infected With Multiresistant Gram-negative Bacteria. NCT01060891. Available at: http:\/\/clinicaltrials.gov\/ (last accessed 1 December 2011)."},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2334-5-1","article-title":"Toxicity after prolonged (more than four weeks) administration of intravenous colistin","volume":"5","author":"Falagas","year":"2005","journal-title":"BMC Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib54","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/s10096-006-0191-2","article-title":"Effectiveness and nephrotoxicity of intravenous colistin for treatment of patients with infections due to polymyxin-only-susceptible (POS) gram-negative bacteria","volume":"25","author":"Falagas","year":"2006","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib55","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jinf.2008.01.003","article-title":"Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria","volume":"56","author":"Pintado","year":"2008","journal-title":"J Infect"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib56","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ijantimicag.2009.11.016","article-title":"Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant gram-negative bacterial infections","volume":"35","author":"Cheng","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib57","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ijantimicag.2005.09.004","article-title":"Nephrotoxicity of intravenous colistin: a prospective evaluation","volume":"26","author":"Falagas","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib58","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1086\/599225","article-title":"Nephrotoxicity associated with intravenous colistin (colistimethate sodium) treatment at a tertiary care medical center","volume":"48","author":"Hartzell","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib59","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1128\/AAC.01707-09","article-title":"Colistin dosing and nephrotoxicity in a large community teaching hospital","volume":"54","author":"Deryke","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib60","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ijantimicag.2009.06.028","article-title":"Clinical characteristics and risk factors of colistin-induced nephrotoxicity","volume":"34","author":"Kim","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib61","doi-asserted-by":"crossref","first-page":"c284","DOI":"10.1159\/000320746","article-title":"Early acute kidney injury is a risk factor that predicts mortality in patients treated with colistin","volume":"117","author":"Ko","year":"2011","journal-title":"Nephron Clin Pract"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib62","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jinf.2010.11.013","article-title":"Risk factors for colistin-associated nephrotoxicity","volume":"62","author":"Rattanaumpawan","year":"2011","journal-title":"J Infect"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib63","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/cid\/cir611","article-title":"Incidence of and risk factors for colistin-associated nephrotoxicity in a large academic health system","volume":"53","author":"Pogue","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib64","doi-asserted-by":"crossref","first-page":"R204","DOI":"10.1186\/cc2872","article-title":"Acute renal failure\u2014definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group","volume":"8","author":"Bellomo","year":"2004","journal-title":"Crit Care"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib65","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1086\/514732","article-title":"Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii","volume":"28","author":"Levin","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib66","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1086\/599226","article-title":"Nephrotoxicity of colistin: new insight into an old antibiotic","volume":"48","author":"Falagas","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib67","doi-asserted-by":"crossref","first-page":"R27","DOI":"10.1186\/cc3995","article-title":"Toxicity of polymyxins: a systematic review of the evidence from old and recent studies","volume":"10","author":"Falagas","year":"2006","journal-title":"Crit Care"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib68","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1055\/s-2007-996407","article-title":"Optimizing use of colistin and polymyxin B in the critically ill","volume":"28","author":"Nation","year":"2007","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib69","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1086\/650582","article-title":"Intravenous and inhalational colistin-induced respiratory failure","volume":"50","author":"Wahby","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib70","doi-asserted-by":"crossref","first-page":"e1018","DOI":"10.1016\/j.ijid.2010.08.001","article-title":"Hypersensitivity pneumonitis due to high-dose colistin aerosol therapy","volume":"14","author":"Leong","year":"2010","journal-title":"Int J Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib71","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.rmed.2008.11.018","article-title":"Inhaled colistin as monotherapy for multidrug-resistant gram (\u2013) nosocomial pneumonia: a case series","volume":"103","author":"Falagas","year":"2009","journal-title":"Respir Med"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib72","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s10096-008-0620-5","article-title":"Inhaled aminoglycosides in cancer patients with ventilator-associated gram-negative bacterial pneumonia: safety and feasibility in the era of escalating drug resistance","volume":"28","author":"Ghannam","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib73","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1086\/657242","article-title":"Aerosolized plus intravenous colistin versus intravenous colistin alone for the treatment of ventilator-associated pneumonia: a matched case-control study","volume":"51","author":"Kofteridis","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib74","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/j.1469-0691.2009.03040.x","article-title":"Inhaled colistin as adjunctive therapy to intravenous colistin for the treatment of microbiologically documented ventilator-associated pneumonia: a comparative cohort study","volume":"16","author":"Korbila","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib75","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1086\/432583","article-title":"Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa","volume":"41","author":"Kwa","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib76","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S1684-1182(10)60050-3","article-title":"Aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii pneumonia: experience in a tertiary care hospital in northern Taiwan","volume":"43","author":"Lin","year":"2010","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib77","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.rmed.2007.10.011","article-title":"Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant gram-negative bacteria: a prospective study","volume":"102","author":"Michalopoulos","year":"2008","journal-title":"Respir Med"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib78","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1186\/cc3020","article-title":"Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant gram-negative bacteria in patients without cystic fibrosis","volume":"9","author":"Michalopoulos","year":"2005","journal-title":"Crit Care"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib79","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1093\/jac\/dkq360","article-title":"Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by gram-negative bacteria","volume":"65","author":"Rattanaumpawan","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib80","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ijantimicag.2009.10.005","article-title":"Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients","volume":"35","author":"Falagas","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib81","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/jac\/dkq069","article-title":"Effectiveness and safety of colistin: prospective comparative cohort study","volume":"65","author":"Paul","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib82","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1128\/AAC.01271-08","article-title":"Does the activity of the combination of imipenem and colistin in vitro exceed the problem of resistance in metallo-beta-lactamase-producing Klebsiella pneumoniae isolates?","volume":"53","author":"Souli","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib83","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ijantimicag.2007.07.007","article-title":"Comparative activities of colistin, rifampicin, imipenem and sulbactam\/ampicillin alone or in combination against epidemic multidrugresistant Acinetobacter baumannii isolates producing OXA-58 carbapenemases","volume":"30","author":"Tripodi","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib84","first-page":"161","article-title":"Antibacterial activity of carbapenem-based combinations against multidrug-resistant Acinetobacter baumannii","volume":"93","author":"Pongpech","year":"2010","journal-title":"J Med Assoc Thai"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib85","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ijantimicag.2005.10.012","article-title":"In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units","volume":"27","author":"Timurkaynak","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib86","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1684-1182(10)60049-7","article-title":"In vitro synergistic antimicrobial effect of imipenem and colistin against an isolate of multidrugresistant Enterobacter cloacae","volume":"43","author":"Lin","year":"2010","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib87","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1128\/AAC.01768-09","article-title":"In vitro double and triple bactericidal activities of doripenem, polymyxin B, and rifampin against multidrugresistant Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli","volume":"54","author":"Urban","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib88","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.diagmicrobio.2010.01.004","article-title":"Activity of doripenem with and without levofloxacin, amikacin, and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii","volume":"67","author":"Pankuch","year":"2010","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib89","doi-asserted-by":"crossref","first-page":"5685","DOI":"10.1128\/AAC.05298-11","article-title":"Synergistic killing of multidrugresistant Pseudomonas aeruginosa at multiple inocula by colistin combined with doripenem in an in vitro PK\/PD model","volume":"55","author":"Bergen","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib90","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1469-0691.1999.tb00095.x","article-title":"In vitro assessment of colistin's antipseudomonal antimicrobial interactions with other antibiotics","volume":"5","author":"Rynn","year":"1999","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib91","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1128\/AAC.47.3.905-909.2003","article-title":"Synergistic activity of colistin and ceftazidime against multiantibiotic-resistant Pseudomonas aeruginosa in an in vitro pharmacodynamic model","volume":"47","author":"Gunderson","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib92","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1179\/joc.2003.15.3.235","article-title":"In vitro interaction of colistin and rifampin on multidrug-resistant Pseudomonas aeruginosa","volume":"15","author":"Giamarellos-Bourboulis","year":"2003","journal-title":"J Chemother"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib93","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0732-8893(01)00258-9","article-title":"Interactions of colistin and rifampin on multidrug-resistant Acinetobacter baumannii","volume":"40","author":"Giamarellos-Bourboulis","year":"2001","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib94","doi-asserted-by":"crossref","first-page":"5316","DOI":"10.1128\/AAC.00922-10","article-title":"Potent synergy and sustained bactericidal activity of a vancomycin\u2013colistin combination versus multidrug-resistant strains of Acinetobacter baumannii","volume":"54","author":"Gordon","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib95","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1093\/jac\/dkr069","article-title":"In vitro activity of teicoplanin combined with colistin versus multidrug-resistant strains of Acinetobacter baumannii","volume":"66","author":"Wareham","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib96","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/jac\/dkm178","article-title":"In vitro effect of minocycline and colistin combinations on imipenem-resistant Acinetobacter baumannii clinical isolates","volume":"60","author":"Tan","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib97","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1469-0691.2008.02061.x","article-title":"Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies","volume":"14","author":"Petrosillo","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib98","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1128\/AAC.01571-06","article-title":"Activity of colistin against heteroresistant Acinetobacter baumannii and emergence of resistance in an in vitro pharmacokinetic\/pharmacodynamic model","volume":"51","author":"Tan","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib99","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/jac\/dkl512","article-title":"In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates","volume":"59","author":"Owen","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib100","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1093\/jac\/dkq226","article-title":"fAUC\/MIC is the most predictive pharmacokinetic\/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models","volume":"65","author":"Dudhani","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib101","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1128\/AAC.49.8.3136-3146.2005","article-title":"Combination therapy with intravenous colistin for management of infections due to multidrug-resistant gram-negative bacteria in patients without cystic fibrosis","volume":"49","author":"Kasiakou","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib102","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1469-0691.2004.01043.x","article-title":"Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic","volume":"11","author":"Michalopoulos","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib103","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1179\/joc.2006.18.6.648","article-title":"Clinical and microbiological efficacy of colistin therapy alone or in combination as treatment for multidrug resistant Pseudomonas aeruginosa diabetic foot infections with or without osteomyelitis","volume":"18","author":"Tascini","year":"2006","journal-title":"J Chemother"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib104","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1086\/379611","article-title":"Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosa","volume":"37","author":"Linden","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib105","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1136\/thx.52.11.987","article-title":"Intravenous colistin sulphomethate in acute respiratory exacerbations in adult patients with cystic fibrosis","volume":"52","author":"Conway","year":"1997","journal-title":"Thorax"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib106","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jinf.2005.11.019","article-title":"Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii","volume":"53","author":"Motaouakkil","year":"2006","journal-title":"J Infect"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib107","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/jac\/dkm509","article-title":"Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections","volume":"61","author":"Bassetti","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib108","unstructured":"Colistin Versus Colistin Plus Fosfomycin for Infections Caused by MDR Acinetobacter baumannii. NCT01297894. Available at: http:\/\/clinicaltrials.gov\/ (last accessed 1 December 2011)."},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib109","unstructured":"Colistin Plus Rifampicin in MDR P. aeruginosa and A. baumanii. NCT01297855. Available at: http:\/\/clinicaltrials.gov\/ (last accessed 1 December 2011)."},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib110","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ijantimicag.2010.11.029","article-title":"Clinical implications of beta-lactam\u2013aminoglycoside synergism: systematic review of randomised trials","volume":"37","author":"Marcus","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib111","first-page":"182","article-title":"Intrathecal colistin for treatment of multidrug resistant (MDR) Pseudomonas aeruginosa after neurosurgical ventriculitis","volume":"18","author":"Baiocchi","year":"2010","journal-title":"Infez Med"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib112","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3171\/jns.2005.102.5.0915","article-title":"Intrathecal colistin for treatment of highly resistant Pseudomonas ventriculitis. Case report and review of the literature","volume":"102","author":"Gump","year":"2005","journal-title":"J Neurosurg"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib113","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1345\/aph.1E485","article-title":"Intrathecal colistin and sterilization of resistant Pseudomonas aeruginosa shunt infection","volume":"39","author":"Quinn","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib114","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1001\/jama.2009.850","article-title":"International differences in the treatment of sepsis: are they justified?","volume":"301","author":"Kellum","year":"2009","journal-title":"JAMA"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib115","doi-asserted-by":"crossref","first-page":"R47","DOI":"10.1186\/cc5780","article-title":"Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review","volume":"11","author":"Cruz","year":"2007","journal-title":"Crit Care"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib116","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1001\/jama.2009.856","article-title":"Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial","volume":"301","author":"Cruz","year":"2009","journal-title":"JAMA"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib117","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/jac\/dkq108","article-title":"Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection","volume":"65","author":"Hirsch","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib118","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/jac\/dkn469","article-title":"Aminoglycoside drugs in clinical practice: an evidence-based approach","volume":"63","author":"Leibovici","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib119","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/jac\/dkm193","article-title":"Efficacy and safety of aminoglycoside monotherapy: systematic review and meta-analysis of randomized controlled trials","volume":"60","author":"Vidal","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib120","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1128\/AAC.41.5.1127","article-title":"Monotherapy versus beta-lactam\u2013aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study","volume":"41","author":"Leibovici","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib121","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1128\/AAC.01020-07","article-title":"Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality","volume":"52","author":"Schwaber","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib122","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1128\/AAC.00627-10","article-title":"Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis","volume":"54","author":"Paul","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib123","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1093\/jac\/dkr242","article-title":"Efficacy and safety of tigecycline: a systematic review and meta-analysis","volume":"66","author":"Yahav","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib125","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1007\/s00134-005-2691-4","article-title":"Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections: a prospective cohort study","volume":"31","author":"Reina","year":"2005","journal-title":"Intensive Care Med"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib126","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1007\/s00134-007-0675-2","article-title":"Safety and efficacy of colistin compared with imipenem in the treatment of ventilator-associated pneumonia: a matched case-control study","volume":"33","author":"Kallel","year":"2007","journal-title":"Intensive Care Med"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib127","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1128\/AAC.01015-06","article-title":"Colistin is effective in treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in cancer patients","volume":"51","author":"Hachem","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib128","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1183\/09031936.00156906","article-title":"Ventilator-associated pneumonia due to colistin susceptible-only microorganisms","volume":"30","author":"Rios","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib129","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ijid.2006.09.011","article-title":"Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand","volume":"11","author":"Koomanachai","year":"2007","journal-title":"Int J Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib130","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1093\/jac\/dkn128","article-title":"Ampicillin\/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp","volume":"61","author":"Oliveira","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib131","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jinf.2008.04.002","article-title":"Efficacy and safety of high-dose ampicillin\/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia","volume":"56","author":"Betrosian","year":"2008","journal-title":"J Infect"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib132","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-2334-9-26","article-title":"Safety and effectiveness of colistin compared with tobramycin for multi-drug resistant Acinetobacter baumannii infections","volume":"9","author":"Gounden","year":"2009","journal-title":"BMC Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib133","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2169\/internalmedicine.50.4270","article-title":"Efficacy and safety of colistin in the treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in patients with hematologic malignancy: a matched pair analysis","volume":"50","author":"Durakovic","year":"2011","journal-title":"Intern Med"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib134","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3346\/jkms.2011.26.3.325","article-title":"The outcomes of using colistin for treating multidrug resistant Acinetobacter species bloodstream infections","volume":"26","author":"Lim","year":"2011","journal-title":"J Korean Med Sci"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib135","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/jac\/dkq390","article-title":"Polymyxin B versus other antimicrobials for the treatment of Pseudomonas aeruginosa bacteraemia","volume":"66","author":"Kvitko","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib136","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1128\/AAC.47.8.2659-2662.2003","article-title":"Polymyxin B nephrotoxicity and efficacy against nosocomial infections caused by multiresistant gram-negative bacteria","volume":"47","author":"Ouderkirk","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib137","doi-asserted-by":"crossref","first-page":"R78","DOI":"10.1186\/cc2358","article-title":"Intravenous colistin in the treatment of sepsis from multiresistant gram-negative bacilli in critically ill patients","volume":"7","author":"Markou","year":"2003","journal-title":"Crit Care"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib138","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s15010-009-8342-x","article-title":"Effectiveness and safety of colistin for the treatment of multidrug-resistant Pseudomonas aeruginosa infections","volume":"37","author":"Montero","year":"2009","journal-title":"Infection"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib139","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4103\/0972-5229.45074","article-title":"Safety and efficacy of polymyxin B in multidrug resistant gram-negative severe sepsis and septic shock","volume":"12","author":"Ramasubban","year":"2008","journal-title":"Indian J Crit Care Med"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib140","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/j.1469-0691.2006.01559.x","article-title":"Effectiveness and nephrotoxicity of colistin monotherapy vs. colistin\u2013meropenem combination therapy for multidrug-resistant Gramnegative bacterial infections","volume":"12","author":"Falagas","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2011.03734.x_bib124","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1086\/374337","article-title":"Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP","volume":"36","author":"Garnacho-Montero","year":"2003","journal-title":"Clin Infect Dis"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14626987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14626987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T15:57:13Z","timestamp":1593273433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14626987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":140,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S1198743X14626987"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03734.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}